EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
Kroger expands wellness efforts in communities nationwide
Throughout September, participating Kroger Family of Stores locations will host wellness-focused events every Friday and Saturday.
Aryna Sabalenka celebrates becoming Moroccanoil's newest Global Ambassador
Spotted in NYC: Aryna Sabalenka steps out pre-match with signature glossy waves to celebrate becoming Moroccanoil's newest Global Brand Ambassador.
Novavax partners secure Nuvaxovid approvals for 2026-2027 season
XFG-adapted COVID-19 vaccine has been approved in the U.S., European Union and Japan.
Shoppers Foundation for Women’s Health invests $600K in 15 community partners across Canada
The organizations receiving funding through the Foundation’s Community Grants Program are addressing a range of needs across the women’s health landscape.